Heartflow, Inc.

HTFL
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001464521

Price chart

Open-market purchases and sales by HTFL insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Sep 21, 20266:19 PM ETSep 18, 2026Rogers CampbellChief Medical OfficerSSaleCommon Stock−19.68K$50.15−$987.05K79.96K−19.8%SEC10b5-1
Sep 18, 20268:46 PM ETSep 17 – Sep 18, 2026Verghese VikramChief Financial OfficerSSaleCommon Stock.−24.35K$50.5542−$1.23M155.18K−13.6%SEC10b5-1
Sep 15, 20267:44 PM ETSep 11 – Sep 15, 2026Verghese VikramChief Financial OfficerSSaleCommon Stock.−34.98K$50.0818−$1.75M179.53K−16.3%SEC10b5-1
Sep 14, 20266:41 PM ETSep 10 – Sep 11, 2026Farquhar John C.M.Chief Executive OfficerSSaleCommon Stock−38.9K$46.7765−$1.82M321.91K−10.8%SEC10b5-1
Sep 10, 20265:24 PM ETSep 8, 2026Verghese VikramChief Financial OfficerSSaleCommon Stock.−6.64K$50.0319−$332.21K214.5K−3.0%SEC10b5-1

The largest institutional positions in HTFL at the end of Q2 2026.

Institutions holding HTFL in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Bain Capital Life Sciences Investors, LLC8,448,158$247.87M14.74%−2,000,000−19.1%Reduced
WELLINGTON MANAGEMENT GROUP LLP7,864,226$230.74M0.04%−4,118,057−34.4%Reduced
BlackRock, Inc.5,197,747$152.5M0.00%+3,735,163+255.4%Added
FMR LLC4,820,944$141.45M0.01%−576,858−10.7%Reduced
VANGUARD PORTFOLIO MANAGEMENT LLC3,584,428$105.17M0.00%+1,538,490+75.2%Added